[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]. [electronic resource]
Producer: 20170421Description: 332-343 p. digitalISSN:- 1769-6917
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Autografts
- Breast Neoplasms -- drug therapy
- Cancer Care Facilities
- Carcinoma -- drug therapy
- Combined Modality Therapy -- methods
- Cyclophosphamide -- administration & dosage
- Female
- Genes, BRCA1
- Genes, BRCA2
- Genes, erbB-2
- Hematopoietic Stem Cell Transplantation
- Humans
- Melphalan -- administration & dosage
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prognosis
- Retrospective Studies
- Thiotepa -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.